Company: ACHV
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0000950170-25-036831
Chunk: 135

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-03-11
Form: 10-K
Item: Item 8
Chunk 135
---
2023

    2022

    Operating Activities:

    Net loss
     
    $
    (39,827
    )
     
    $
    (29,815
    )
     
    $
    (42,350
    )

    Adjustments to reconcile net loss to net cash used in operating activities:

    Depreciation and amortization [note 5]

    229

    228

    236

    Stock-based compensation [note 11[c], note 11[d] and note 11[e]]

    5,325

    3,439

    3,270

    Shares issued as settlement with trade vendor

    —

    273

    26

    Accrued interest on SVB convertible debt [note 9]

    799

    1,216

    1,170

    Amortization of 2024 SVB convertible term loan transaction costs [note 9]

    23

    —

    —

    Accretion of discount on modification of debt [note 9]

    365

    430

    —

    Loss on extinguishment of 2023 SVB convertible term loan [note 9]

    283

    —

    —

    Contingent consideration [note 6 and note 7]

    621

    528

    —

    Changes in operating assets and liabilities:

    Grant receivable [note 4]

    111

    (6
    )

    48

    Prepaid expenses and other assets

    (765
    )

    1,176

    (931
    )

    Accounts payable

    1,332

    (1,042
    )

    799

    Accrued liabilities other

    222

    (32
    )

    55

    Accrued clinical liabilities

    797

    (1,449
    )

    376

    Accrued compensation

    716

    633

    (263
    )

    Lease obligation

    (1
    )

    (58
    )

    (5
    )

    Net cash used in operating activities

    (29,770
    )

    (24,479
    )

    (37,569
    )

    Financing Activities:

    Proceeds from exercise of warrants [note 11[g]]

    682

    227

    24